1. Home
  2. HQY vs ASND Comparison

HQY vs ASND Comparison

Compare HQY & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HQY
  • ASND
  • Stock Information
  • Founded
  • HQY 2002
  • ASND 2006
  • Country
  • HQY United States
  • ASND Denmark
  • Employees
  • HQY N/A
  • ASND N/A
  • Industry
  • HQY Business Services
  • ASND Biotechnology: Pharmaceutical Preparations
  • Sector
  • HQY Consumer Discretionary
  • ASND Health Care
  • Exchange
  • HQY Nasdaq
  • ASND Nasdaq
  • Market Cap
  • HQY 8.4B
  • ASND 7.7B
  • IPO Year
  • HQY 2014
  • ASND 2015
  • Fundamental
  • Price
  • HQY $108.60
  • ASND $152.43
  • Analyst Decision
  • HQY Buy
  • ASND Strong Buy
  • Analyst Count
  • HQY 13
  • ASND 14
  • Target Price
  • HQY $111.23
  • ASND $197.36
  • AVG Volume (30 Days)
  • HQY 683.2K
  • ASND 519.7K
  • Earning Date
  • HQY 03-18-2025
  • ASND 02-12-2025
  • Dividend Yield
  • HQY N/A
  • ASND N/A
  • EPS Growth
  • HQY 218.51
  • ASND N/A
  • EPS
  • HQY 1.09
  • ASND N/A
  • Revenue
  • HQY $1,150,344,000.00
  • ASND $376,478,932.00
  • Revenue This Year
  • HQY $20.65
  • ASND $47.51
  • Revenue Next Year
  • HQY $9.04
  • ASND $88.30
  • P/E Ratio
  • HQY $99.74
  • ASND N/A
  • Revenue Growth
  • HQY 18.47
  • ASND 36.34
  • 52 Week Low
  • HQY $65.01
  • ASND $111.09
  • 52 Week High
  • HQY $115.59
  • ASND $161.00
  • Technical
  • Relative Strength Index (RSI)
  • HQY 49.08
  • ASND 66.26
  • Support Level
  • HQY $110.50
  • ASND $118.03
  • Resistance Level
  • HQY $115.22
  • ASND $157.37
  • Average True Range (ATR)
  • HQY 2.90
  • ASND 6.50
  • MACD
  • HQY -0.64
  • ASND 3.62
  • Stochastic Oscillator
  • HQY 7.97
  • ASND 87.44

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Share on Social Networks: